
Will the World Health Organization recognize a cure for HIV/AIDS before November 13, 2018?
Background: Note: This is a long-term market.
On November 13, 2008, German hematologist Gero Huetter claimed to have cured an HIV-infection in a patient. The patient was a 42-year old American citizen with advanced leukemia in addition to HIV. Huetter injected the patient with bone marrow from a donor who was naturally resistant to HIV. After 20 months, Huetter says that the patient has not exhibited signs of HIV.
Bone marrow transplants kill about one-third of all patients who receive them. For this reason, "they can't be justified ethically." Also, Huetter's claims have not been verified. Before antivirals were introduced in the 1990's, bone marrow transplants were tried as a desparate method to halt the AIDS epidemic.
This market will settle as 'yes,' if the WHO, or its successor, recognizes any 'cure' for AIDS or HIV before November 13, 2018. 'Treatment' will not count for this market.
Additional information:
http://www.time.com/time/health/article/0,8599,1858843,00.html
On November 13, 2008, German hematologist Gero Huetter claimed to have cured an HIV-infection in a patient. The patient was a 42-year old American citizen with advanced leukemia in addition to HIV. Huetter injected the patient with bone marrow from a donor who was naturally resistant to HIV. After 20 months, Huetter says that the patient has not exhibited signs of HIV.
Bone marrow transplants kill about one-third of all patients who receive them. For this reason, "they can't be justified ethically." Also, Huetter's claims have not been verified. Before antivirals were introduced in the 1990's, bone marrow transplants were tried as a desparate method to halt the AIDS epidemic.
This market will settle as 'yes,' if the WHO, or its successor, recognizes any 'cure' for AIDS or HIV before November 13, 2018. 'Treatment' will not count for this market.
Additional information:
http://www.time.com/time/health/article/0,8599,1858843,00.html
Settlement details:As reported by a major mainstream news source.
- Activity: H$1,500 |
- Predictions: 8 |
Comments: 1
Suspend date: Mon 12th Nov 2018 9pm PST (8 years to go)
Initial likelihoods: Yes: 40%
Action history:
Changed Description Thu 13th Nov 2008 4:22pm PST by
tisha![This user is an admin [Admin]](http://www.hubdub.com/images/icon_admin.gif)
: show details
... is a long-term market. <.<br/> <br/> On November 13, ... not exhibited signs of HIV. <.<br/> <br/> Bone marrow transplants ... to halt the AIDS epidemic. <.<br/> <br/> This market will ... or HIV before November 13, 20082018. 'Treatment' will not count for this market. <.<br/> <br/> Additional information: <:<br/> <a href="http://www.
Suspend date: Mon 12th Nov 2018 9pm PST (8 years to go) details
Predictions (8)
29 weeks ago
Comments (1)
Related News
This news is selected automatically based on the question, its background, options and tags
This news is selected automatically based on the question, its background, options and tags
score: 10
Bone Marrow Transplantation 27 weeks ago
Extract not available.
score: 10
Forbes.com 27 weeks ago
biologic designed to rapidly produce mature neutrophils and platelets in vivo and facilitate long-term engraftment in patients undergoing bone marrow or cord blood transplantation, or being treated for chemotherapy- or radiation-induced neutropenia among
score: 10
Reuters 27 weeks ago
biologic designed to rapidly produce mature neutrophils and platelets in vivo and facilitate long-term engraftment in patients undergoing bone marrow or cord blood transplantation, or being treated for chemotherapy- or radiation-induced neutropenia among
score: 10
Reuters 27 weeks ago
to patients enrolled in clinical trials, based on findings from David Grinblatt, MD, of the North Shore University Health System, Evanston, IL. In community-based settings, he showed patients with MDS achieved transfusion independence within the first
score: 10
Forbes.com 27 weeks ago
to patients enrolled in clinical trials, based on findings from David Grinblatt, MD, of the North Shore University Health System, Evanston, IL. In community-based settings, he showed patients with MDS achieved transfusion independence within the first

Related Tags








SOMEONE has a sense of humour...
Please log in or join to add a comment